NEW YORK, Oct. 31 (GenomeWeb News) - Orchid BioSciences and Tepnel Life Sciences announced today that Tepnel will buy Orchid's diagnostics unit for $4.3 million.
Registering provides access to this and other free content.
Already have an account?Login Now.
Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.
By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.
Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.
In Nature this week: a Danish reference genome, and more.